Home▸Andropause Testosterone Therapy▸Testosterone Replacement Therapy Eligibility Simulator

👨 Testosterone Replacement Therapy Eligibility Simulator

The simulator evaluates eligibility criteria for testosterone replacement therapy, considering factors such as symptoms and underlying conditions.

Andropause Testosterone Therapy2DModerate60 FPS
Testosterone Replacement Therapy Eligibility Simulator ↗ Open standalone

Symptom Criteria for Hypogonadism

Placeholder: core symptoms guide initial suspicion of low testosterone.

  • Low libido: Key symptom (Placeholder short note)
  • Fatigue: Key symptom (Placeholder short note)
  • Mood change: Key symptom (Placeholder short note)
  • ≥3 symptoms: Threshold (Placeholder short note)

Recognizing symptom patterns

Placeholder: clinicians review symptom checklist before ordering labs.

Placeholder: symptoms alone never confirm diagnosis without labs.

Two Confirmed Morning Low-Testosterone Readings

Placeholder: diagnosis requires two separate morning total testosterone draws.

  • AM only: Draw time (Placeholder short note)
  • <300 ng/dL: Cutoff (Placeholder short note)
  • 2 required: Repeat draws (Placeholder short note)
  • Total T: Assay (Placeholder short note)

Why two readings matter

Placeholder: single low value can be transient or lab error.

Placeholder: confirmed low readings anchor the diagnosis.

Ruling Out Reversible Causes

Placeholder: exclude pituitary, thyroid, medication, and lifestyle factors.

  • Pituitary: Check (Placeholder short note)
  • Thyroid: Check (Placeholder short note)
  • Medications: Check (Placeholder short note)
  • Obesity/sleep: Check (Placeholder short note)

Secondary cause workup

Placeholder: labs and history screen for reversible contributors.

Placeholder: treating underlying cause may resolve low testosterone.

Shared Decision-Making on Risks

Placeholder: patient and clinician weigh benefits against known risks.

  • Cardiovascular: Risk (Placeholder short note)
  • Fertility: Risk (Placeholder short note)
  • Prostate: Risk (Placeholder short note)
  • Polycythemia: Risk (Placeholder short note)

Discussing tradeoffs

Placeholder: informed consent covers monitoring and side effects.

Placeholder: shared decisions respect patient goals and risk tolerance.

Candidacy Determination

Placeholder: final eligibility combines labs, symptoms, and consent.

  • Eligible: Outcome (Placeholder short note)
  • Not eligible: Outcome (Placeholder short note)
  • Further workup: Outcome (Placeholder short note)
  • 3 months: Follow-up (Placeholder short note)

Final determination

Placeholder: eligibility recommendation issued after full review.

Placeholder: ongoing monitoring follows any therapy decision.
⚙ Under the hood

The simulator evaluates eligibility criteria for testosterone replacement therapy, considering factors such as symptoms and underlying conditions.

CanvasBiomedicine

2D · HTML5 Canvas 2D · 60 FPS target · runs fully client-side, no install

What did you find?

Add reproduction steps (optional)